Though other S100 proteins have been shown to increase with retinoid therapy in models of cancer including teratocarcinoma, breast cancer, and gastric carcinoma [21–23], this is the first report of increased S100A2 expression by either rexinoids or TZDs. This evidence concerns the gene S100A2 and breast cancer.